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A B S T R A C T   
In vitro cell models offer a unique opportunity for conducting toxicology research, and the human lung adeno-
carcinoma cell line A549 is commonly used for toxicology testing strategies. It is essential to determine whether 
the response of these cells grown in different laboratories is consistent. In this study, A549 cells were grown 
under both submerged and air-liquid interface (ALI) conditions following an identical cell seeding protocol in 
two independent laboratories. The cells were switched to the ALI after four days of submerged growth, and their 
behaviour was compared to submerged conditions. The membrane integrity, cell viability, morphology, and (pro- 
)inflammatory response upon positive control stimuli were assessed at days 3, 5, and 7 under submerged con-
ditions and at days 5, 7, and 10 at the ALI. Due to the high variability of the results between the two laboratories, 
the experiment was subsequently repeated using identical reagents at one specific time point and condition (day 
5 at the ALI). Despite some variability, the results were more comparable, proving that the original protocol 
necessitated improvements. In conclusion, the use of detailed protocols and consumables from the same pro-
viders, special training of personnel for cell handling, and endpoint analysis are critical to obtain reproducible 
results across independent laboratories.   
1. Introduction 
In vitro lung cell cultures offer cost-effective, robust, and high- 
throughput platforms to conduct inhalation toxicology research. To 
date, most of the in vitro lung models, particularly those representing the 
alveolar region, are used for scientific research. However, to have an in 
vitro model accepted as a valid alternative to animal testing (for testing 
both chemicals and particulate (micron and nano-sized)), towards a 
regulatory perspective, the robustness, reproducibility, and predictive 
value of the cell system must be demonstrated (Hiemstra et al., 2018). 
The alveolar region of the lung is of particular interest to those 
studying the effects of aerosolized materials or drugs with diameters 
lower than 2 μm (Semmler-Behnke et al., 2007; Geiser and Kreyling, 
2010). The alveolar epithelium is composed of alveolar epithelial type I 
cells and type II cells (Hiemstra et al., 2018). Type I cells cover 95% of 
the alveolar surface, forming together with endothelial cells and the 
common basal membrane, a 0.2 μm thin tissue layer to enable optimal 
gas exchange between the lung and the bloodstream (Crapo et al., 1982). 
Type II cells are responsible for the production of lung surfactants, 
which ensures that the alveolar region does not collapse during venti-
lation (Whitsett and Weaver, 2015). 
Both cell lines and primary cells have their advantages and disad-
vantages in terms of handling and in vivo representation. These must be 
taken into consideration (as well as the region of the lung aiming to be 
mimicked) when choosing the correct cells for any in vitro lung model 
(Hiemstra et al., 2018; Lacroix et al., 2018; Upadhyay and Palmberg, 
2018). 
The A549 cell line, representing alveolar epithelial type II cells 
(Lieber et al., 1976), is a widely investigated cell line (Foster et al., 1998; 
Cooper et al., 2016; Guo et al., 2016; Bisig et al., 2019). The A549 cell 
line has been demonstrated to be successful for studying cytotoxicity, 
oxidative stress, and/or the (pro-)inflammatory response following 
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acute (usually 24 hours (h) up to 72 h) exposure to different materials at 
the air-liquid interface (ALI). On the other hand, when investigating 
occupational exposures, which generally occur repeatedly over a long 
period of time, and severe adverse effects such as pulmonary fibrosis, 
asthma; long-term sub-chronic experiments need to be performed 
(Chortarea et al., 2017; Chortarea et al., 2019; Barosova et al., 2020b; 
Drasler et al., 2020). Therefore it is crucial to test if A549 cells are 
suitable for long-term experiments at the ALI and thus a representative 
model to investigate critical long-term exposure scenarios. 
As well as selecting the appropriate cell line for a specific study or 
analysis, it is crucial to consider the length, the route, and the type of 
exposure. Various studies have been performed in order to justify the 
enhanced complexity of ALI exposures compared to submerged expo-
sures (Lenz et al., 2013; Hilton et al., 2019). It has been shown that 
biological responses of the cells indeed change upon switching to the ALI 
from submerged conditions (Ohlinger et al., 2019). It has further been 
reported that exposing the cell of interest at the ALI to aerosols of 
inhalable and poorly soluble nanomaterials generates different toxicity 
patterns and results in different biological effect levels compared to 
similar cultures undergoing submerged exposure conditions (Loret et al., 
2016; Gohlsch et al., 2019). 
Comparing data between laboratories remains a significant chal-
lenge, as most research laboratories usually do not work with shared, 
standardised, and detailed experimental protocols. In addition, 
addressing reproducibility and reliability in cell culture research re-
quires a detailed description of the biological test system of interest. This 
is an important consideration when transitioning models to a regulatory 
setting and assessing their potential for toxicology research (exposure to 
both chemicals and particles). A recent review (Faria et al., 2018) has 
identified four critical components required as minimum information 
required for bio-nano publications (it is important to note that these 
requirements can also be applied to studies on any toxicology research), 
as well as being the basis of Good In Vitro Method Practices (GIVIMP) for 
chemical toxicology studies (OECD, 2018). These include; (i) reusability 
and the ability to compare new data to old, (ii) quantification of old and 
new materials; (iii) practicality and ensuring the experimental proced-
ure can be completed in most laboratories; and finally, (iv) quality, 
ensuring all data published are “reliable and reproducible”. The above- 
mentioned criteria have also been identified by previous studies using 
A549 cells (Elliott et al., 2017), highlighting the importance of cell 
handling, cell medium usage, as well as the source and passage number 
of the cells. 
To be able to compare the experiments among laboratories, specific 
conditions need to be followed. For this purpose, Standard Operating 
Procedures (SOPs) are essential tools as a set of detailed instructions that 
document a routine approach so that it may be strictly adhered to 
experimentally. The development and use of SOPs are a necessary part of 
any successful quality system. It provides individuals with information 
to perform different steps correctly and facilitates consistency in terms 
of both the quality and the integrity of the experiment. The development 
and use of SOPs minimize variation and promote quality through the 
consistent implementation of a procedure among various handlers and 
laboratories. SOPs are even more useful when published methods are 
being utilized. For example, if an SOP is written for a standard analytical 
method, the SOP should specify the procedures to be followed in more 
detail than they appear in the published method (Agency, 2007). Once 
the SOP has been developed and approved by a laboratory and/or a team 
of researchers from several laboratories, it can then be validated through 
a process outlined by the European Centre for the Validation of Alter-
native Methods (ECVAM), which aims to break the validation down into 
its main components. The ECVAM process lays the ground to establish 
inter-laboratory transferability and identify any potential intra- and 
inter-laboratory variation (Hartung et al., 2004). 
Within the scope of establishing a validation component between 
laboratories, this study aimed to define an SOP to evaluate the growth 
and differentiation of A549 cells. Cells were grown under both 
submerged and ALI conditions, and their subsequent culturing for up to 
10 days was investigated. Different biological identifiers such as cell 
morphology, barrier characteristics, and release of (pro-)inflammatory 
mediators upon exposure to inflammatory stimuli were assessed. The 
corresponding results were compared among the two laboratories in 
order to provide further insight into the transferability of SOPs between 
different research laboratories. 
2. Methods 
2.1. Cell cultures 
The corresponding LOT numbers of A549 cells were used in the 
specified laboratories for both approaches 1 and 2. 
Approach 1: The A549 cells were obtained from ATCC, USA (ATCC® 
CCL-185™, LOT: 62783414 (AMI), and 63913710 (IVTG)). The cells 
were cultured at 37◦ in 5% CO2. The A549 cells were cultivated in RPMI- 
1640 medium (Gibco, USA), which was supplemented with 10% heat- 
inactivated fetal bovine serum (FBS, Gibco, USA), 2 mM L-Glutamine 
(Gibco, USA), 100 U/mL penicillin, and 100 μg/mL streptomycin 
(Gibco, USA). The supplemented RPMI-1640 is further cited as the 
complete cell medium (CCM). 
A549 cells were passaged when ~80% confluent and used at pas-
sages of 4–18 for all tissue culture experiments. The cells were seeded on 
the apical side of Falcon® permeable support with a 3.0 μm pore-sized 
transparent membrane (Corning, VWR, Switzerland, or UK, respec-
tively) in a 12-well plate setting. Cells were seeded at a density of 2.78 ×
105 cells/cm2 in 0.5 mL of CCM, and 1.5 mL CCM was added to the basal 
compartment. On day (D) 4, after the cell seeding, the medium was 
changed, and the cells were further cultured at either submerged con-
ditions (0.5 mL apical medium, 1.5 mL basal medium) or at the ALI with 
0.6 mL of CCM in the basal compartment and the apical compartment 
was exposed to air (no medium). The medium was changed every second 
day, and the samples were collected at D3, D5, and D7 for submerged 
conditions and D5 (corresponding to D1 at the ALI, i.e., 4 + 1), D7 (4 +
3), and D10 (4 + 6) at the ALI (Fig. 1). 
Approach 2: A549 (ATCC® CCL-185™ were obtained from ATCC, 
USA, (LOT: 62783414 (AMI), and 63913710 (IVTG), the same batches as 
used in approach 1)) and were cultured at 37 ◦C in 5% CO2. The A549 
cells were cultivated in RPMI-1640 medium (Gibco, USA), which was 
further supplemented with 10% heat-inactivated FBS, LOT: 42G1189K 
(Gibco, USA), 2 mM L-Glutamine (Gibco, USA), 100 U/mL penicillin, 
100 μg/mL streptomycin (Gibco, USA). The supplemented RPMI-1640 is 
further cited as the complete cell medium (CCM). 
In both laboratories, the A549 cells were passaged when ~80% 
confluent and used at passages 6, 8, and 10 for the experiments. The cells 
were seeded on the apical side of the inserts at a density of 2.78 × 105 
cells/cm2 in 0.5 mL of CCM, and 1.5 mL CCM was added to the basal 
compartment. On D4, after the cell seeding, the medium was replen-
ished. The cells were further cultured at the ALI with 0.6 mL of CCM 
aliquoted into the basal compartment (and apical compartment exposed 
to air (no medium)). The medium was changed after 24 h at the ALI 
(corresponding to D1 at the ALI, i.e., 4 + 1) when the cells were exposed 
to either lipopolysaccharide (LPS) or tumor necrosis factor-α (TNF-α) 
both at [1 μg/mL]. 
2.2. Exposures to positive controls 
The cellular response upon exposure to potent (pro-)inflammatory 
stimulants LPS (from Escherichia coli at [1 μg/mL], LOT: 029M4025V, 
Sigma-Aldrich, CH, and UK, respectively) and to TNF-α (at [1 μg/mL], LOT: 
354857, Immunotools, Germany) (Bigatto et al., 2015; Bisig et al., 2019), 
was investigated 24 h post-exposure. Each cell culture insert was exposed 
to 50 μL of LPS or TNF-α diluted to working concentration in CCM from the 
apical side. The negative controls were exposed to 50 μL of CCM; this 
method is referred to as pseudo-ALI exposure (Endes et al., 2014). 
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2.3. Trypan blue exclusion assay 
Cellular viability was determined using the trypan blue exclusion 
assay (the details of the method are explained in the SOP implemented 
for this study, supplementary file 1) 24 h upon exposure. Briefly, the 
cells were trypsinized (Trypsin-ethylenediaminetetraacetic acid (EDTA) 
(0.05%), Gibco) for 5 min at 37 ◦C on the apical side, then 1 mL of CCM 
was applied. Subsequently, the cells were carefully scraped from the cell 
culture insert using a cell scraper. Then, 10 μL of the collected cell 
suspensions were mixed with 10 μL trypan blue dye (0.4%) prior to the 
cell counting. The numbers of viable and dead cells were determined 
using a hemocytometer, and the percentage of viable cells was calcu-
lated from the total cell number counted. 
2.4. Transepithelial electrical resistance (TEER) 
TEER analysis only was carried out for approach 1. The TEER values 
were measured with STX01 electrode probes connected to an Epithelial 
Volt-Ohm Meter (Millicell® ERS-2, EMD Millipore Corporation, MA, 
USA). During the measurements, the CCM was replaced by PBS (at room 
temperature; 1 mL of PBS was added to the lower compartment, and 1 
mL of PBS was added to the upper compartment) for both submerged 
and ALI conditions. The TEER measurements were performed at AMI on 
two defined spots on each membrane inserts, and mean values were 
calculated. TEER values were measured at IVTG 4 times per membrane 
insert, and a mean was calculated. The illustration displaying the spe-
cific locations on the lab inserts where TEER measurements were taken 
at AMI and IVTG are presented in Fig. S1. TEER values were corrected 
for membrane interference regardless of the TEER method used. The 
mean values were multiplied by the growth area of membrane inserts (i. 
e., 0.9 cm2), and the results are presented in [Ω*cm2]. 
2.5. Immunostaining 
Immunostaining was not a part of the implemented SOP and was 
only carried out as a part of approach 1. 
AMI procedure: The cells were fixed with 4% paraformaldehyde 
solution (in PBS) at room temperature for 15 min at different time points 
to visualize the cell morphology and assess the development of the 
monolayer. Next, the cells were washed with PBS. The cells were sub-
sequently treated with 0.1 M glycine in PBS for another 15 min. To 
permeabilize the cell membrane, the cells were treated with 0.2% Triton 
X-100 in PBS for 15 min. Phalloidin rhodamine (R-415; Molecular 
Probes, Life Technologies, Switzerland) was used to stain the F-actin 
cytoskeleton at a 1:50 dilution, while the nucleus was stained with 4′,6- 
Diamidine-2′-phenylindole dihydrochloride (DAPI) ([100 μg/mL]; 
Sigma Aldrich, Switzerland) at a 1:50 dilution, respectively. For optical 
analysis, the inserts were embedded in Glycergel (DAKO Schweiz AG, 
Switzerland). The samples were visualized using an inverted laser 
scanning confocal microscope (LSM 710, Zeiss, Germany). Image pro-
cessing was performed with a cell image analysis software, IMARIS 
(Bitplane AG, Switzerland). 
IVTG procedure: The cells were fixed with 4% paraformaldehyde 
solution (in PBS) at room temperature for 10 min at different time points 
to visualize the cell morphology and assess the development of mono-
layer. Next, the cells were washed with PBS. The cells were subsequently 
treated with 0.1 M glycine in PBS for another 15 min. To permeabilize 
the cell membrane, the cells were treated with 0.2% Triton X-100 in PBS 
for 15 min. Phalloidin, Alexa Fluor 633 (A22284; Invitrogen, UK) was 
used to stain the F-actin cytoskeleton at a 1:200 dilution. DAPI was then 
used to counterstain the nuclei of the cells. For optical analysis, the in-
serts were embedded in Glycergel (DAKO Schweiz AG, Switzerland). 
The samples were visualized using an inverted laser scanning confocal 
microscope (LSM 710, Zeiss, Germany). Image processing was per-
formed with a cell image analysis software, IMARIS (Bitplane AG, 
Switzerland). 
2.6. Lamellar body (LB) staining 
At the ALI D1 cells were washed with PBS and then stained using 10 
μM quinacrine (Sigma) for 1 min before being washed with PBS and 
fixed with 4% paraformaldehyde solution (in PBS) at room temperature 
for 10 min, as previously described by (Chintagari et al., 2010). The 
samples were visualized using an inverted laser scanning confocal mi-
croscope (LSM 710, Zeiss, Germany). Image processing was performed 
with a cell image analysis software, IMARIS (Bitplane AG, Switzerland). 
2.7. (Pro-)inflammatory response detection 
LPS or TNF-α was applied to investigate the (pro-)inflammatory 
responsiveness of the A549 cells. The response was measured by quan-
tifying the amount of the (pro-)inflammatory mediators released into 
the basal medium via Enzyme-Linked Immunosorbent Assay (ELISA). 
The cell culture supernatant was collected at 24 h post-exposure and 
Fig. 1. An illustrative scheme summarizing exposure 
conditions as well as their duration and the corre-
sponding sample collection time points that were 
followed in approach 1. The cells were seeded and 
cultivated under submerged conditions for 4 days. 
Then, the two parallel sets of experiments were car-
ried out. The first set of experiments were conducted 
for 3 more days under submerged conditions. Samples 
were collected on days 3, 5, and 7. For the second 
parallel set of experiments, the cells were cultivated 
at the ALI conditions for 6 more days, and samples 
were collected on day 1 (4 + 1), day 3 (4 + 3), and 
day 6 (4 + 6).   
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analyzed for (pro-)inflammatory mediator levels of Interleukin (IL)-8 
(Cat no. DY208) and IL-6 (Cat no. DY206, LOT: P209026) using DuoSet 
kits from R&D systems (Biotechne, CH or Abingdon, UK) according to 
the manufacturer’s instructions. The samples for IL-8 analysis were 
diluted 10× (untreated samples and LPS-treated samples) and 20×
(TNF-α treated samples), respectively. The samples were analyzed in 
triplicate per repetition and repeated on three independent occasions (n 
= 3), and absorbance was measured at 450 nm with a background 
correction at 570 nm. Extrapolation of protein concentration was carried 
out from a standard curve of known concentrations (IL-8 (0–2000 pg/ 
mL) and IL-6 (0–600 pg/mL)). 
2.8. Data and statistical analysis 
The data and the corresponding statistical analyses were carried out 
using GraphPad Prism 8 (San Diego, USA). All data are presented as the 
mean ± standard deviation (SD). All endpoints were assessed upon three 
independent cell culture experiments (n = 3). The data were analyzed 
via the Mann–Whitney U test, with the null hypothesis, the true median 
difference is zero. This statistical hypothesis test is generally considered 
as the non-parametric equivalent of the Student’s t-Test. Accordingly, 
the test does not assume that the difference between the samples is 
normally distributed or that the variances of the two populations are 
equal. The test determines the p-value, and a small p-value suggests that 
it is unlikely that the null hypothesis is true. The decision is made at a 
given significance level (α), and if p < α, the hypothesis is rejected. In our 
case, the significance level was 0.05. 
3. Results and discussion 
3.1. Inter-laboratory testing approach 
A comparison between two independent laboratories: Bio-
Nanomaterials Group, Adolphe Merkle Institute (AMI), University of 
Fribourg, Switzerland, and In Vitro Toxicology Group (IVTG), School of 
Medicine, Swansea University, UK, was carried out on identical cell lines 
purchased from the same provider (American Tissue Culture Collection 
(ATCC), USA). Experimental cultures were used between passage 
numbers 4 to 18. The BioNanomaterials group at AMI, University of 
Fribourg, and the IVTG, at Swansea University Medical School, 
compared their experimental findings, consisting of seeding and moni-
toring A549 epithelial cells. The obtained results were compared be-
tween the groups and analyzed for reproducibility. The SOP 
implemented for this study (PATROLS_3101, is attached as an inde-
pendent supplementary file) was established within the European Ho-
rizon 2020 project: Physiologically Anchored Tools for Realistic 
Nanomaterial Hazard Assessment (PATROLS, Grant Agreement No 
760813), which was then revised further after reviewing the results 
(PATROLS_3101_a, also attached as a part of the Supplementary 
Information). 
The following two approaches were subsequently adopted: 
Approach 1: The main SOP was followed for cell culture experiments 
using all reagents from the same provider but independent batches 
(different LOT numbers). Several time points were investigated (submerged 
conditions at day 3, day 5, and day 7 and ALI conditions at day 1 (4 + 1), 
day 3 (4 + 3), and day 6 (4 + 6), and the two conditions were compared. A 
scheme depicting the experimental approach is presented in Fig. 1. 
Approach 2: A more controlled experimental plan was implemented 
(the previous SOP was revised and then implemented for this approach), 
where the cells were treated and samples were collected at the same time 
points, using the cells with the same passage numbers, using fetal bovine 
serum (FBS) and positive controls with the same LOT number, were 
introduced. All the experiments were performed in the morning (be-
tween 9 and 12 a.m. in both laboratories; the difference in time zones 
was taken into account). Finally, the cells exposed on day 1 at the ALI 
(5th day in total) were investigated, and the data obtained in both 
laboratories were compared. A summary scheme illustrating the 
experimental approach is presented in Fig. 2. 
3.2. Results from approach 1 
The A549 cell line is one of the most studied and a widely used 
human lung cell line, as it offers unique features corresponding to 
alveolar epithelial cells type II, i.e., cuboidal shape and surfactant 
release at the apical side of the cells when cultured at the ALI, resulting 
in surface tension similar to values measured in vivo (Blank et al., 2006). 
Previous studies have demonstrated that primary alveolar epithelial 
type II cells cultured under classical submerged cell culture conditions 
showed a loss of alveolar epithelial type II cells phenotype and surfac-
tant production capacity, resulting in cell morphology alteration (Lin 
et al., 1996). In a recent study, the A549 cell line was investigated both 
under submerged conditions and at the ALI (Wu et al., 2018). The results 
revealed an induced expression of alveolar epithelial-specific cell 
markers: AQP-5 and SPC in the ALI, indicating partial alveolar epithelial 
cell properties of A549 (Wu et al., 2018). 
Many studies have investigated cytotoxicity, oxidative stress, and 
(pro-)inflammatory effects in response to (nano-)materials for up to 72 h 
(Rothen-Rutishauser et al., 2005; Rothen-Rutishauser et al., 2008; Endes 
et al., 2014; Chortarea et al., 2015; Drasler et al., 2018; Hilton et al., 
2019; Barosova et al., 2020a). The overgrowing of A549 cells was re-
ported to be occurring after 96 h of exposure at the ALI (Hilton et al., 
2019). Using these time frames for approach 1, it was observed that cell 
viability under submerged conditions decreased ~ 10% at IVTG and ~ 
15% at AMI at the end of 7 days (Fig. 3a). It was observed that until D3, 
in both laboratories, the A549 cells proliferated continuously (Fig. 3b). 
This resulted in a consistent increase in total cell number from 2.78 ×
105 cells/cm2 at D0 to 106 cells/cm2 at the end of D3 (Fig. 3b). However, 
after D3, the cell density results started to differ between the two lab-
oratories. The cell density remained constant at AMI, while in IVTG, the 
cell density reached up to ~ 5 × 106 cells/cm2 at the end of D7 (Fig. 3b). 
On the other hand, at the end of D7, it was recorded that the trans-
epithelial electrical resistance (TEER) reached ~ 20 Ω * cm2 at IVTG, 
while the TEER values reached ~ 40 Ω * cm2 at AMI under submerged 
conditions (Fig. 3c). The schematic shown in Fig. S1 presents the specific 
locations on the inserts where TEER measurements were taken at AMI 
and IVTG. Although the difference in the final TEER values recorded at 
the end of the experiment under submerged conditions may seem sig-
nificant, they are considered within the same range. This is due to the 
inherent nature of the TEER measurement technique, which is often 
prone to error as the chip-specific conditions such as electrode place-
ment and temperature variations highly influence the readouts (Srini-
vasan et al., 2015; Elbrecht et al., 2016). 
The representative LSM images of untreated A549 cells cultured 
under submerged conditions at D5 and D7 in both laboratories are 
presented in Fig. 3d, and no differences in the morphology of the cells 
were detected. 
The responsiveness of A549 cells to LPS and TNF-α treatments was 
evaluated via release levels of IL-8 and IL-6 (pro-)inflammatory media-
tors. Under submerged conditions, it was observed that recorded re-
sponses for both IL-8 and IL-6 were higher when the cells were exposed 
to TNF-α in both laboratories (Fig. 3e). Interestingly, IVTG results 
showed that IL-6 release was not detectable from the A549 cultures on 
D3 and D7 under submerged conditions (Fig. 3e). 
Next, the results were assessed for the ALI culturing conditions. 
Under ALI exposure conditions, the cell viability was found to decrease 
by ~ 6% at IVTG, but ~ 49% at AMI at the end of 10 days (Fig. 4a). The 
cells reached up to 1.3 × 106 cells/cm2 in both labs at D7, but at D10, the 
cell density had increased up to 1.7 × 106 cells/cm2 (at AMI), while at 
IVTG, it increased up to 5.8 × 106 cells/cm2 (Fig. 4b). 
Other epithelial cells, such as the hAELVi cell line from the alveolar 
region (Kuehn et al., 2016), or Calu-3 or 16HBE14o− from the bronchial 
region (Wan et al., 2000; Xu et al., 2013; Dekali et al., 2014), are able to 
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form tight junctions and reach higher values than A549 cells, in the 
range of hundreds to thousands Ω * cm2. The A549 cells cultured at the 
ALI reached TEER values up to ~ 40–50 Ω * cm2 in both labs at the end 
of the experiment (Fig. 4c), consistent with previously reported TEER 
monitoring results (Buckley et al., 2011; Ren et al., 2016). However, 
these values are still low compared to the above-mentioned cell lines. 
The LSM images of A549 cells cultured under ALI conditions at D5 
(day 1 at the ALI) and D7 (day 3 at the ALI) in both laboratories are 
presented in Fig. 4d. Additional LSM images are also presented 
demonstrating the prescence of lamellar bodies (LB) within the epi-
theilal type-II ‘like’ cells, indicating the expected cell type differentia-
tion of the A549 cells under the specific culture conditions used within 
this study (Fig. S2). It was observed that the cells started to show multi- 
layer formation at the end of D7 in both laboratories (the multi-layer 
formations can be seen in the y-x projection of merged optical z-stacks 
of Fig. 4d). Although there were no morphological changes detected, the 
appearance of multi-layers of cells suggests that the A549 cell culture 
model is not suitable for cultivation at later time-points. 
ALI conditions showed a similar (TNF-α vs. LPS) response trend for 
both (pro-)inflammatory mediator release profiles. The results showed 
that the cells responded more to TNF-α treatment. Interestingly, IVTG 
results showed that IL-6 release was not detectable from the A549 cul-
tures on D10 in response to TNF-α exposure (Fig. 4e). 
As our results confirm, although the cell culture is responsive for up 
to 10 days (4 days submerged followed by 6 days at ALI) to the positive 
control stimuli, the cell layer overgrew into several multi-layers (Fig. 4d) 
with no increase in TEER (Fig. 4c), i.e., no improvement in barrier 
integrity, resulting in less physiological relevance. It is noteworthy that 
A549 cells are adenocarcinoma cells with unlimited capacity of prolif-
eration but have limited differentiation capacity. In the light of this in-
formation, it was previously hypothesized that A549 cells could 
differentiate into alveolar epithelial type II cells at early time points, but 
they might retain their carcinoma cell properties along with a reduced 
capacity of differentiation under long-term ALI culture conditions (Wu 
et al., 2018). 
3.3. Results for approach 2 
As significantly different (pro-)inflammatory response results were 
observed for approach 1, the experiments were further optimized and 
harmonized between the two laboratories. Additional details were 
introduced in the protocol to be adopted by the two laboratories. Further 
information included a synchronized cell growth time, passaging, and 
seeding. Also, it was ensured that both laboratories used an FBS sample 
with the same LOT number. Finally, the same batch of positive controls 
were included in the experimental design. Due to the formation of multi- 
layers detected post 24 h under ALI conditions (Fig. 4d), in approach 2, 
the cell viability along with IL-6 and IL-8 release were investigated only 
for 24 h post-exposure. The cells were seeded and cultivated under 
submerged conditions for four days. Next, the cells were cultivated at 
ALI conditions for two days, and then exposed to the specific positive 
controls (LPS and TNF-α, both at [1 μg/mL]) was carried out at the end 
of 24 h at the ALI (Fig. 2). 
According to the results obtained in approach 2, a similar pattern in 
exposure to LPS and TNF-α treatments was observed in both cell viability 
and (pro-)inflammatory response results. Although the differences be-
tween laboratories are still remarkable (Fig. 5), overall, the results of 
approach 2 are comparable to the results from approach 1. 
Several inter-laboratory comparison studies have been published 
(Godschalk et al., 2013; Elliott et al., 2017); however, the comparison is 
based more on toxicological assay results than the cell culture condi-
tions. It was shown that even if the cells were to be acquired from the 
same batch, the standard laboratory consumables (such as cell culture 
dishes, serum supplements, etc.) tend to be different, not only in terms of 
LOT number but also in terms of the provider (Elliott et al., 2017). 
Therefore, we used an optimized approach and focused on laboratory 
consumables. To the best of our knowledge, the presented study, which 
we adopted in approach 2 of this work, is the first one specifically 
focusing on the cell culture conditions while also ensuring the providers 
are the same for the laboratory consumables. 
As can be seen from the results, when strictly following the SOP and 
ensuring the consumables are from the same providers with the same 
LOT numbers during the cell culturing step, the results become com-
parable between the two laboratories (Fig. 5). The cell response is 
affected by the composition of serum, which is an essential supplement 
for cell culture media (Veranth et al., 2008; Corradi et al., 2012). The 
major cell media supplement for most cell lines is FBS, which provides 
several important biological molecules such as albumin, anti-
chymotrypsin, apolipoproteins, biotin, and growth-supporting factors 
required for cell growth (Baker et al., 1988). The serum prevents the 
possible mechanical damage on cells, which may occur as a result of 
stirring or cell scraping. The serum is known to change the 
Fig. 2. An illustrative scheme summarizing exposure conditions as well as their duration and the sample collection time point that were implemented in approach 2. 
The cells were seeded and cultivated under submerged conditions for 4 days. Next, the cells were cultivated at the ALI conditions for 2 days, and samples were 
collected at the end of the experiment. 
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physicochemical properties of the media, such as viscosity, osmolality, 
buffering capacity, and diffusion rate. Furthermore, FBS can be used for 
a wide range of cell cultures despite the various requirements of 
different cells. In approach 1, we used FBS from the same supplier 
(Gibco) but used different batches (different LOT numbers). It is worth 
noting that differences in serum composition may be present when ac-
quired from different batches, even from the same provider (Zheng 
et al., 2006). The only significant difference between the two tested 
batches of FBS (based on certificates of analysis from the provider) is in 
γ-globulin. However, the reported values of γ-globulin for both batches 
of FBS are in the accepted range based on the reference ranges provided 
by the provider (Table S1). Low levels of γ-globulin in FBS (compared to 
serum from adult animals) are needed for successful cell culturing, as 
high levels of γ-globulin may inhibit cell growth and proliferation 
(Rauch et al., 2011). A batch of FBS with a higher content of γ-globulin 
was used in AMI; however, no statistically significant decrease (p >
0.05) compared to IVTG results was observed in cell proliferation 
(Figs. 3c and 4c). This is also confirmed by the LSM images, which 
Fig. 3. The results from both laboratories for submerged conditions adopted in approach 1 comparing (a) cell viability, (b) cell proliferation (number of cells), (c) 
transepithelial electrical resistance, (d) cell morphology, and (e) the release profiles of (pro-)inflammatory mediators: IL-8 and IL-6. Data are presented as mean ±
standard deviation, n = 3. *indicates rejected hypothesis, i.e., statistically significant increase (p < 0.05) compared to the untreated cells. The error bars on the LSM 
images are 20 μm. 
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demonstrated that cell proliferation was not inhibited; in fact, a multi- 
layer cell formation was detected (Fig. 4d). The use of the same FBS 
batch across different laboratories poses many obstacles. Thus the 
optimization and use of alternative (i.e., animal-free) serum approach 
for A549 cell growth should be considered. 
The cell viability response was found to be significantly different 
(Fig. 5a) between the two laboratories. We attribute this difference to 
the factor of human error, as cell scrapping and cell counting are 
strongly affected by the handler, even though an identical experimental 
procedure is followed. Furthermore, although the cells were treated the 
same way and were obtained from the same provider (ATCC, USA), 
possible differences between batches play a critical role in the cell 
Fig. 4. The results from both laboratories for ALI exposure conditions adopted in approach 1 comparing (a) cell viability, (b) cell proliferation (number of cells), (c) 
transepithelial electrical resistance, (d) cell morphology, and (e) the release profiles of (pro-)inflammatory mediators: IL-8 and IL-6. Data are presented as mean ±
standard deviation, n = 3. *indicates rejected hypothesis, i.e., statistically significant increase (p < 0.05) compared to the untreated cells. The error bars on the LSM 
images is 20 μm. 
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response. This hypothesis is confirmed when (pro-)inflammatory 
mediator release profiles were assessed (Fig. 5b and c). 
The (pro-)inflammatory response was investigated via IL-6 and IL-8 
release analysis. The results showed that the same pattern (TNF-α trig-
gered a more significant response than LPS) for both mediators. But vast 
differences in release levels were observed between the two laboratories 
(Fig. 5). Although human factors can play a role in the difference, batch 
(LOT number) of cells play a vital role in observed distinctions. Based on 
the presented data, the original SOP was revised (The SOP is provided as 
a part of the Supplementary Information: “PATROLS_3101_a”), specif-
ically for Section 5.9 titles as “Quality control and acceptance criteria”, 
where the need for the use of cells with the same LOT number is 
emphasized. 
The results show, that repeating the experiment with a different 
batch of cells, FBS, or positive control can strongly affect the outcome, as 
shown in approach 1. Different batches of cells potentially introduce 
experimental variability because the exact difference between the 
batches is not disclosed by the provider. Furthermore, batch-to-batch 
variability related to variations in the concentrations of serum compo-
nents, in addition to the unknown exact composition of FBS, can also 
ultimately lead to experimental variability and limit inter-laboratory 
reproducibility (van der Valk et al., 2018), as we demonstrated in 
approach 1. Finally, the composition of the positive control, in this case, 
LPS and TNF-α, also remains unknown unless the same LPS and TNF-α 
with the same LOT numbers are used. Taken these three primary sources 
of variability that can ultimately affect the outcome together with the 
differences in cell handling due to different human handling, it is un-
avoidable to have differences in results. 
In summary, establishing a detailed SOP protocol is vital for per-
forming inter-laboratory comparisons. As it was shown, not only the 
source of cells or laboratory consumables is important, but using the 
same batch from the same provider is crucial. Table 1 summarizes the 
importance of each component of these approaches on the inter- 
laboratory differences. When performing the inter-laboratory compari-
son, we recommend careful planning of the experiment down to the 
individual batches of all consumables required and time-harmonization 
of the experiment plan, which leads to more consistent results as pre-
sented in approach 2 (Fig. 5). Therefore, we conclude that our improved 
SOP for approach 2 can serve as a reference for future inter-laboratory 
comparisons and corresponding endpoint analysis. 
4. Conclusion 
In conclusion, the experience reported in this study clearly indicates 
that the use of detailed SOPs, together with the use of consumables from 
the same providers with the same LOT numbers, are both critical to 
obtain reproducible results across independent laboratories. 
Our inter-laboratory comparison study of culturing A549 cells 
confirmed the suitability of the adopted approach (i.e., the SOP developed 
for approach 2). It resulted in better reproducibility across the two labo-
ratories (compared to the initial SOP developed for approach 1). This two- 
tiered study not only provides valuable insight for future inter-laboratory 
comparisons but also demonstrates that when repeating an experiment, 
identification of possible sources of discrepancies in results and adopting 
corresponding revisions to the SOPs are the keys to achieve reproducibility 
and reliability in a method. The results also show that even when working 
with a cell line that is easy to handle, the comparability of results from 
different laboratories should be treated with caution. Furthermore, special 
training of personnel is recommended to harmonize the human handling of 
the different cultivation and endpoint analysis steps. 
Fig. 5. The results from both laboratories following approach 2, comparing (a) viability and normalized cytokine (b) IL-8, and (c) IL-6 release measurements 24 h 
post-exposure at the ALI. Data are presented as mean ± standard deviation, n = 3. *indicates rejected hypothesis, i.e., statistically significant increase (p < 0.05) 
compared to the untreated cells. 
Table 1 
A summary table of differences in Approach 1 and 2 and their effects on differences in the investigated endpoints at day 5 (4 + 1). *Cellular viability was not 
comparable between the laboratories, However, it was consistent across the exposures within each individual laboratory. **IL-8 concentration for approach 2 after 
exposure to TNF-α was not comparable between the laboratories, however in each laboratory the concentration was significantly increased when compared to the 
appropriate negative control. “yes” indicates comparable results between AMI and IVTG, while “no” indicates that the results are not comparable. N/A indicates an 
endpoint was not completed.   
The same cell batch The same FBS batch The same positive control batch The same consumables (cell culture inserts, etc.) 
Approach 1 No No No Yes 
Approach 2 No Yes Yes Yes    
TEER Cell proliferation Cell viability consistency across exposure Pro-inflammatory response  
LPS TNF-α 
Approach 1 Yes Yes Yes IL-8 No Yes 
IL-6 Yes No 
Approach 2 N/A N/A Yes* IL-8 Yes No** 
IL-6 Yes Yes  
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